Referred to the House Committee on the Judiciary.
The bill, titled "Gio’s Law," would add a new part to Title I of the Omnibus Crime Control and Safe Streets Act of 1968 to establish a federal grant program administered by the Attorney General that funds purchases of epinephrine products and standardized training for State, local, and tribal law enforcement. The Attorney General must develop or identify a training curriculum within 180 days, and grant applicants must certify that their jurisdiction provides civil liability protection to officers who administer epinephrine.
Whether law enforcement should take on expanded medical/first-responder roles (progressive wary of policing medicalization; conservative cautious about mission creep).
Relative to its intended legislative type, this bill establishes a clear substantive federal grant program with funding, assigns implementation responsibility to the Attorney General (and BJS/HHS for reporting and outreach), and specifies some timelines and definitions.
The bill, titled "Gio’s Law," would add a new part to Title I of the Omnibus Crime Control and Safe Streets Act of 1968 to establish a federal grant program administered by the Attorney General that funds purchases of epinephrine products and standardized training for State, local, and tribal law enforcement.
The Attorney General must develop or identify a training curriculum within 180 days, and grant applicants must certify that their jurisdiction provides civil liability protection to officers who administer epinephrine.
The bill defines "epinephrine product" to include auto-injectors and non-injection epinephrine delivery devices, authorizes $25 million per year in appropriations for FY2026–2030, and requires annual public reporting by the Bureau of Justice Statistics on epinephrine administrations by law enforcement.
On content alone this is a narrow, low-controversy public-health/grant bill with modest cost and clear implementation paths—characteristics that correlate with successful enactment. The principal limiting factors are reliance on future appropriations (authorization does not guarantee funding), possible legal questions about police administering medication and state liability regimes, and ordinary procedural hurdles in the Senate.
Relative to its intended legislative type, this bill establishes a clear substantive federal grant program with funding, assigns implementation responsibility to the Attorney General (and BJS/HHS for reporting and outreach), and specifies some timelines and definitions. The statutory architecture is adequate to authorize action but leaves significant administrative and safeguards details to subsequent rulemaking or grant guidance.
Whether law enforcement should take on expanded medical/first-responder roles (progressive wary of policing medicalization; conservative cautious about mission creep).
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether law enforcement should take on expanded medical/first-responder roles (progressive wary of policing medicalization; conservative cautious about mission creep).
A mainstream progressive would likely view the bill as a modest, potentially life-saving public-health measure but with important caveats.
They would appreciate the emphasis on saving lives and standardized training, while worrying about expanding medical roles for police and the potential for unequal application in communities of color.
They would also be concerned that funding and attention might be better spent strengthening EMS, community health responders, and ensuring clear protections and oversight.
A pragmatic moderate would likely see this bill as a low-cost, targeted public-safety measure with clear, relatively narrow goals.
They would welcome standardized training and data reporting as tools for accountability, and view the grant structure and 5-year authorization as appropriately limited federal involvement.
Their concerns would center on implementation details—clarity of curricula, how civil-liability certification will work across states, and ensuring funds are used effectively rather than creating unfunded mandates.
A mainstream conservative would likely view the bill as a modest, practical grant program that supports first responders and could save lives, but with some reservations about federal involvement and potential mission creep.
Because the program is grant-based rather than a federal mandate, it is more acceptable; however, conservatives may object to recurring federal spending, data collection requirements, and expansion of non-law-enforcement medical responsibilities for police.
They would favor limiting federal reach, ensuring state primacy on liability protections, and clearly preventing the program from becoming a permanent new federal entitlement.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone this is a narrow, low-controversy public-health/grant bill with modest cost and clear implementation paths—characteristics that correlate with successful enactment. The principal limiting factors are reliance on future appropriations (authorization does not guarantee funding), possible legal questions about police administering medication and state liability regimes, and ordinary procedural hurdles in the Senate.
The bill has not accumulated any surfaced votes yet.
Whether law enforcement should take on expanded medical/first-responder roles (progressive wary of policing medicalization; conservative ca…
On content alone this is a narrow, low-controversy public-health/grant bill with modest cost and clear implementation paths—characteristics…
Relative to its intended legislative type, this bill establishes a clear substantive federal grant program with funding, assigns implementation responsibility to the Attorney General (and BJS/HHS for reporting and outre…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.